Kusajili – Clinical trials directory

Result of your search per sponsor: Olivier Olivier, MD

Woman Max 99 years
Olivier Olivier, MD Update Il y a 4 ans

REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression The objective of this randomized phase II is to evaluate the benefit of regorafenib for ovarian patients who reported a confirmed elevated CA-125 level under surveillance or bevacizumab, c...

Country France
organs None
Specialty None

Opened trial

More information